Citigroup
LEGN icon

Citigroup’s Legend Biotech LEGN Stock Holding History

Citigroup’s Portfolio LEGN Stock Details LEGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.62M Sell
56,247
-23,702
-30% -$639K ﹤0.01% 3087
2026
Q1 		$1.45M Buy
79,949
+4,952
+7% +$94.4K ﹤0.01% 2873
2025
Q4 		$1.63M Buy
74,997
+27,521
+58% +$788K ﹤0.01% 2793
2025
Q3 		$1.55M Buy
47,476
+5,130
+12% +$189K ﹤0.01% 2884
2025
Q2 		$1.5M Buy
42,346
+4,183
+11% +$136K ﹤0.01% 2900
2025
Q1 		$1.29M Sell
38,163
-7,385
-16% -$265K ﹤0.01% 3061
2024
Q4 		$1.48M Buy
45,548
+3,550
+8% +$147K ﹤0.01% 3045
2024
Q3 		$2.05M Sell
41,998
-1,482
-3% -$78.9K ﹤0.01% 2645
2024
Q2 		$1.93M Buy
43,480
+3,776
+10% +$174K ﹤0.01% 2381
2024
Q1 		$2.23M Sell
39,704
-30,795
-44% -$1.86M ﹤0.01% 2358
2023
Q4 		$4.24M Sell
70,499
-8,895
-11% -$564K ﹤0.01% 1698
2023
Q3 		$5.33M Buy
79,394
+4,427
+6% +$307K ﹤0.01% 1395
2023
Q2 		$5.17M Sell
74,967
-8,103
-10% -$529K ﹤0.01% 1469
2023
Q1 		$4.01M Buy
83,070
+7,265
+10% +$355K ﹤0.01% 1617
2022
Q4 		$3.78M Buy
75,805
+5,491
+8% +$266K ﹤0.01% 1625
2022
Q3 		$2.87M Sell
70,314
-44,082
-39% -$2.07M ﹤0.01% 1896
2022
Q2 		$6.29M Buy
114,396
+53,094
+87% +$2.24M ﹤0.01% 1398
2022
Q1 		$2.23M Buy
61,302
+11,188
+22% +$442K ﹤0.01% 2281
2021
Q4 		$2.34M Buy
50,114
+34,543
+222% +$1.75M ﹤0.01% 2488
2021
Q3 		$788K Buy
15,571
+7,828
+101% +$326K ﹤0.01% 3271
2021
Q2 		$318K Buy
7,743
+7,286
+1,594% +$248K ﹤0.01% 3979
2021
Q1 		$13K Sell
457
-183
-29% -$4.99K ﹤0.01% 5486
2020
Q4 		$18K Buy
+640
New +$18.4K ﹤0.01% 6716

Other funds holding LEGN

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
DM
Deerfield Management New York $9.59B AUM 113.36% 1-Year Est. Return
SCM
Suvretta Capital Management New York $5.47B AUM 131.34% 1-Year Est. Return
HA
HHLR Advisors Grand Cayman, Cayman Islands $832M AUM 32.38% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Westfield Capital Management
Westfield Capital Management Boston, Massachusetts $30.6B AUM 61.81% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $90.7B AUM 77.13% 1-Year Est. Return
KCM
Kynam Capital Management Princeton, New Jersey $1.81B AUM 192.15% 1-Year Est. Return
Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.56% 1-Year Est. Return

Citigroup's LEGN Position: Q2 2026 in Review

Citigroup reduced its Legend Biotech (LEGN) stake by 30% in Q2 2026, selling an estimated $639K and leaving 56,247 shares worth $1.62M. The position accounts for ﹤0.01% of the portfolio, ranked #3087.

Citigroup first reported a position in LEGN in Q4 2020 and has held it in 23 quarters since. The position peaked at $6.29M in Q2 2022. 219 funds tracked by Wall St. Rank hold LEGN as of Q2 2026.

  • Citigroup held 56,247 shares of Legend Biotech worth $1.62M as of Q2 2026.
  • Citigroup sold 23,702 Legend Biotech shares in Q2 2026, an estimated $639K.
  • Legend Biotech made up ﹤0.01% of Citigroup's portfolio in Q2 2026, its #3087 holding.
  • Citigroup first reported a position in Legend Biotech in Q4 2020 and has held it in 23 quarters since.
  • Citigroup's Legend Biotech position peaked at $6.29M in Q2 2022.
  • 219 funds tracked by Wall St. Rank held Legend Biotech as of Q2 2026.

Based on Citigroup's 13F filing for Q2 2026, filed 3 Aug 2026.